Skip to main content

Table 2 Treatment Schedule and Dose

From: A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

Treatment Interval (Cycle Length) No. Patients (%)
N = 120*
Median PLD Dose (mg/m2) PLD Dose
Range (mg/m2)
2 weeks 7 (6) 20 15-20
3 weeks 8 (7) 32 27-40
4 weeks 95 (79) 40 20-50
5 weeks 10 (8) 40 30-50
  1. * Five patients had only one documented cycle of PLD and therefore treatment interval could not be analyzed.